{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:19:47Z","timestamp":1790108387755,"version":"4.0.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To date, evidence to support the risk estimates of peritoneal dialysis (PD)-associated peritonitis after the occurrence of exit-site infection (ESI) is limited. We aimed to investigate the association between ESI and the subsequent risk of PD-associated peritonitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multicenter, retrospective cohort study of adult incident PD patients in Thailand between January 2006 and September 2022. We compared matched pairs (1:1) of individuals who experienced the first episode of ESI with their counterparts who did not experience any ESIs during follow-up. The subsequent risk of PD-associated peritonitis was assessed using multivariable Cox proportional hazards models with shared frailty correction to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Landmark analysis corresponding to the designed landmark time after ESI was conducted (within 1\u202fmonth, 1\u20133\u202fmonths, 3\u20136\u202fmonths, 6\u20139\u202fmonths, and 9\u201312\u202fmonths). Secondary analyses explored causative organisms and ESI severity. An ancillary meta-analysis of all available evidence was summarized using a random-effect model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 5,368 incident PD cases in the cohort, a total of 610 patients were eligible, including 305 incident cases of the first episode of ESI and 305 corresponding matched index cases. The study cohort had a mean age of 59.3\u202fyears; most patients were male (56.7%), and most received continuous ambulatory PD (89.0%). Regarding adjustment for sociodemographic and clinical characteristics, PD practices, and laboratory profiles, the risk of subsequent PD-associated peritonitis was significantly increased among individuals who had experienced an ESI (HR, 5.30; 95% CI, 3.75\u20137.50). Following landmark analysis, the risk of PD-associated peritonitis increased at peak approximately 18-fold (within 1\u202fmonth) and gradually decreased to 2-fold over the designed 9\u201312\u202fmonths. Secondary analyses revealed consistent findings across the causative organism and severity strata of ESIs (HRs ranging from 5.17 to 5.98). An ancillary meta-analytic synthesis supported the main findings [3 included cohort studies;\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f1775; HR, 3.37 (95% CI, 1.35\u20138.41)].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Regarding retrospective cohort analysis with ancillary meta-analytical synthesis, individuals experienced with ESI are at risk of developing PD-associated peritonitis. Effective strategies to prevent PD-associated peritonitis following an ESI episode are warranted to promote patient health and sustainable PD programs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1893696","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:56:48Z","timestamp":1786514208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Exit-site infection and subsequent incident risk of peritoneal dialysis-associated peritonitis: a retrospective cohort study with meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Surapon","family":"Nochaiwong","sequence":"first","affiliation":[{"name":"Department of Bioinformatic and Clinical Epidemiology, Faculty of Medicine, Chiang Mai University","place":["Chiang Mai, Thailand"]},{"name":"Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University","place":["Chiang Mai, Thailand"]},{"name":"Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University","place":["Chiang Mai, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidchanok","family":"Ruengorn","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University","place":["Chiang Mai, Thailand"]},{"name":"Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University","place":["Chiang Mai, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajohnsak","family":"Noppakun","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University","place":["Chiang Mai, Thailand"]},{"name":"Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University","place":["Chiang Mai, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuttaya","family":"Wachiraphansakul","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lampang Hospital","place":["Lampang, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanawat","family":"Vongchaiudomchoke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lampang Hospital","place":["Lampang, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanun","family":"Ngamvichchukorn","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University","place":["Chiang Mai, Thailand"]},{"name":"Division of Nephrology, Department of Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kednapa","family":"Thavorn","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University","place":["Chiang Mai, Thailand"]},{"name":"Ottawa Hospital Research Institute, Ottawa Hospital","place":["Ottawa, ON, Canada"]},{"name":"School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa","place":["Ottawa, ON, Canada"]},{"name":"Institute of Clinical and Evaluative Sciences, ICES uOttawa","place":["Ottawa, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish M.","family":"Sood","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa Hospital","place":["Ottawa, ON, Canada"]},{"name":"Division of Nephrology, Department of Medicine, University of Ottawa","place":["Ottawa, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Knoll","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa Hospital","place":["Ottawa, ON, Canada"]},{"name":"Division of Nephrology, Department of Medicine, University of Ottawa","place":["Ottawa, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichat","family":"Tantraworasin","sequence":"additional","affiliation":[{"name":"Department of Bioinformatic and Clinical Epidemiology, Faculty of Medicine, Chiang Mai University","place":["Chiang Mai, Thailand"]},{"name":"Department of Surgery, Faculty of Medicine, Chiang Mai University","place":["Chiang Mai, Thailand"]},{"name":"Clinical Surgical Research Center, Chiang Mai University","place":["Chiang Mai, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1001\/jama.2024.16338","article-title":"Dialysis for chronic kidney failure: a review","volume":"332","author":"Flythe","year":"2024","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1093\/ndt\/gfae130","article-title":"Global structures, practices, and tools for provision of chronic peritoneal dialysis","volume":"39","author":"Cho","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","article-title":"Epidemiology of peritoneal dialysis outcomes","volume":"18","author":"Bello","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e2237580","DOI":"10.1001\/jamanetworkopen.2022.37580","article-title":"Association between pretransplant dialysis modality and kidney transplant outcomes: a systematic review and meta-analysis","volume":"5","author":"Ngamvichchukorn","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1053\/j.ajkd.2019.09.017","article-title":"Establishing a core outcome set for peritoneal dialysis: report of the SONG-PD (standardized outcomes in nephrology-peritoneal Dialysis) consensus workshop","volume":"75","author":"Manera","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2215\/cjn.0000000000000418","article-title":"Complications of peritoneal dialysis part II: nonmechanical complications","volume":"19","author":"Cheng","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/sdi.12571","article-title":"Innovations in treatment delivery, risk of peritonitis, and patient retention on peritoneal dialysis","volume":"30","author":"Piraino","year":"2017","journal-title":"Semin Dial"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.ajkd.2019.09.016","article-title":"Peritoneal dialysis-related infection rates and outcomes: results from the peritoneal Dialysis outcomes and practice patterns study (PDOPPS)","volume":"76","author":"Perl","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/1744-9987.13726","article-title":"Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients","volume":"26","author":"Sachar","year":"2022","journal-title":"Ther Apher Dial"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2215\/cjn.0000000000000280","article-title":"Peritoneal dialysis-related infections","volume":"19","author":"Cho","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1093\/ndt\/gft002","article-title":"The risk of peritonitis after an exit site infection: a time-matched, case-control study","volume":"28","author":"Lloyd","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1590\/S0101-28002010000200004","article-title":"Predictor factors of peritoneal dialysis-related peritonitis","volume":"32","author":"Lobo","year":"2010","journal-title":"J Bras Nefrol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2215\/cjn.00980112","article-title":"The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients","volume":"7","author":"van Diepen","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"14797","DOI":"10.1038\/s41598-018-33196-2","article-title":"A clinical risk prediction tool for peritonitis-associated treatment failure in peritoneal dialysis patients","volume":"8","author":"Nochaiwong","year":"2018","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s40620-020-00716-1","article-title":"Changes in serum albumin concentrations during transition to dialysis and subsequent risk of peritonitis after peritoneal dialysis initiation: a retrospective cohort study","volume":"33","author":"Noppakun","year":"2020","journal-title":"J Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/07853890.2021.1889023","article-title":"Comparative effectiveness of lactulose and sennosides for the prevention of peritoneal dialysis-related peritonitis: an open-label, randomized, active-controlled trial","volume":"53","author":"Noppakun","year":"2021","journal-title":"Ann Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/medsci13040249","article-title":"Association between peritoneal dialysis-associated peritonitis and the risk of all-cause mortality and cardiovascular death: a time-matched retrospective cohort study","volume":"13","author":"Nochaiwong","year":"2025","journal-title":"Med Sci (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/08968608231172740","article-title":"ISPD catheter-related infection recommendations: 2023 update","volume":"43","author":"Chow","year":"2023","journal-title":"Perit Dial Int"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0140-6736(07)61602-x","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/08898489509525394","article-title":"Correlated individual frailty: an advantageous approach to survival analysis of bivariate data","volume":"5","author":"Yashin","year":"1995","journal-title":"Math Popul Stud"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1177\/0962280220921889","article-title":"A tutorial on frailty models","volume":"29","author":"Balan","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/m16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref25","author":"Wells","year":"2025"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jclinepi.2014.11.023","article-title":"Grading the strength of a body of evidence when assessing health care interventions: an EPC update","volume":"68","author":"Berkman","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/cancers14102566","article-title":"Use of thiazide diuretics and risk of all types of skin cancers: an updated systematic review and meta-analysis","volume":"14","author":"Nochaiwong","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1893696\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:56:49Z","timestamp":1786514209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1893696\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":30,"alternative-id":["10.3389\/fpubh.2026.1893696"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1893696","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1893696"}}